C. Tacchetti, “A comprehensive analysis of Trastuzumab-induced signaling suggests the role of HER2 in several cell processes and highlights alternative targets for HER2- positive breast cancer therapy”, Ital J Anat Embryol, vol. 120, no. 1, p. 71, Sep. 2015.